drugset / Trial / NCT02139501
An Investigation of rhTPO With Different Frequencies in the Management of ITP
Phase 3
Completed
48 enrolled
Shandong University
Shandong Provincial Hospital · collabThe First Affiliated Hospital of Dalian Medical University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The project was undertaking by Qilu Hospital of Shandong University and other well-known hospitals in China. In order to study the efficacy and safety of different dose and frequency Recombinant Human thrombopoietin in treating the primary immune thrombocytopenia (ITP)
Timeline
- Start
- 2014-05
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human thrombopoietin | Protein / enzyme biologic | 300 iu/kg | Intravenous |